CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Zhang, Xiaolong ^a   Chang Li, Xian ^b   Xiao, Xiang ^b   Sun, Rui ^a,c   Tian, Zhigang ^a,c   Wei, Haiming ^a,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; INTERLEUKIN 2; L SELECTIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE REGULATORY T LYMPHOCYTE; ARTICLE; CD4+ CD62L+ MEMORY T LYMPHOCYTE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DEMETHYLATION; EFFECTOR CELL; EPIGENETICS; FOXP3+ REGULATORY T LYMPHOCYTE; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; METHYLATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD45; CELL DIFFERENTIATION; CELL MEMBRANE; DNA METHYLATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; L-SELECTIN; MICE; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885403931     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077322     Document Type: Article

References (52)

1. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27. doi:10.1111/j.0105-2896.2006.00427.x. PubMed: 16903903.
2. Wing K, Fehérvári Z, Sakaguchi S, (2006) Emerging possibilities in the development and function of regulatory T cells. Int Immunol 18: 991-1000. doi:10.1093/intimm/dxl044. PubMed: 16720616.
3. Li XC, Turka LA, (2010) An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 6: 577-583. doi:10.1038/nrneph.2010.101. PubMed: 20683480.
4. de Lafaille MAC, Lafaille JJ, (2009) Natural and Adaptive Foxp3(+) Regulatory T Cells: More of the Same or a Division of Labor? Immunity 30: 626-635. doi:10.1016/j.immuni.2009.05.002. PubMed: 19464985.
5. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227. doi:10.1038/ni1265. PubMed: 16244650.
6. Schramm C, Huber S, Protschka M, Czochra P, Burg J, et al. (2004) TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. Int Immunol 16: 1241-1249. doi:10.1093/intimm/dxh126. PubMed: 15249539.
7. Daniel V, Naujokat C, Sadeghi M, Weimer R, Renner F, et al. (2008) Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl Int 21: 646-660. doi:10.1111/j.1432-2277.2008.00662.x. PubMed: 18298587.
8. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886. doi:10.1084/jem.20030152. PubMed: 14676299.
9. Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, et al. (2008) Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29: 758-770. doi:10.1016/j.immuni.2008.09.018. PubMed: 19006694.
10. Xiao X, Kroemer A, Gao WD, Ishii N, Demirci G, et al. (2008) OX40/OX40L costimulation affects induction of Foxp(3+) regulatory T cells in part by expanding memory T cells in vivo. J Immunol 181: 3193-3201. PubMed: 18713990.
11. Wang J, Huizinga TWJ, Toes REM, (2009) De Novo Generation and Enhanced Suppression of Human CD4(+)CD25(+) Regulatory T Cells by Retinoic Acid. J Immunol 183: 4119-4126. doi:10.4049/jimmunol.0901065. PubMed: 19717521.
12. Tran DQ, Ramsey H, Shevach EM, (2007) Induction of FOXP3 expression in naive human CD4(+)FOXP3(-) T cells by T-cell receptor stimulation is transforming growth factor-beta-dependent but does not confer a regulatory phenotype. Blood 110: 2983-2990. doi:10.1182/blood-2007-06-094656. PubMed: 17644734.
13. Vukmanovic-Stejic M, Zhang Y, Cook JE, Fletcher JM, McQuaid A, et al. (2006) Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J Clin Invest 116: 2423-2433. doi:10.1172/JCI28941. PubMed: 16955142.
14. Kim BS, Kim IK, Park YJ, Kim YS, Kim YJ, et al. (2010) Conversion of Th2 memory cells into Foxp3(+) regulatory T cells suppressing Th2-mediated allergic asthma. Proc Natl Acad Sci U S A 107: 8742-8747. doi:10.1073/pnas.0911756107. PubMed: 20421479.
15. Vukmanovic-Stejic M, Agius E, Booth N, Dunne PJ, Lacy KE, et al. (2008) The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J Clin Invest 118: 3639-3650. doi:10.1172/JCI35834. PubMed: 18924611.
16. Stockinger B, Bourgeois C, Kassiotis G, (2006) CD4+ memory T cells: functional differentiation and homeostasis. Immunol Rev 211: 39-48. doi:10.1111/j.0105-2896.2006.00381.x. PubMed: 16824115.
17. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL, (2010) Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLOS ONE 5: e11469. doi:10.1371/journal.pone.0011469. PubMed: 20661468.
18. Daniel V, Sadeghi M, Wang H, Opelz G, (2011) CD4+CD25+Foxp3+IFN-gamma+ human induced T regulatory cells are induced by interferon-gamma and suppress alloresponses nonspecifically. Hum Immunol 72: 699-707. doi:10.1016/j.humimm.2011.05.020. PubMed: 21664396.
19. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. doi:10.1038/nature04753. PubMed: 16648838.
20. Baron U, Floess S, Wieczorek G, Baumann K, Grützkau A, et al. (2007) DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37: 2378-2389. doi:10.1002/eji.200737594. PubMed: 17694575.
21. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, et al. (2005) BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 21: 4067-4068. doi:10.1093/bioinformatics/bti652. PubMed: 16141249.
22. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E, (2002) Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106: 190-199. doi:10.1046/j.1365-2567.2002.01412.x. PubMed: 12047748.
23. Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, et al. (2006) Persistence of naive CD45RA+ regulatory T cells in adult life. Blood 107: 2830-2838. doi:10.1182/blood-2005-06-2403. PubMed: 16332974.
24. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645. doi:10.1016/j.immuni.2009.04.010. PubMed: 19464986.
25. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, et al. (2009) PD-L1 negatively regulates CD4(+)CD25(+)Foxp3(+) Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-564. doi:10.1172/JCI36604. PubMed: 19229109.
26. Wang W, Lau R, Yu D, Zhu W, Korman A, et al. (2009) PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol 21: 1065-1077. doi:10.1093/intimm/dxp072. PubMed: 19651643.
27. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, et al. (2010) Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812. doi:10.1038/nature08750. PubMed: 20072126.
28. Nagar M, Vernitsky H, Cohen Y, Dominissini D, Berkun Y, et al. (2008) Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells. Int Immunol 20: 1041-1055. doi:10.1093/intimm/dxn062. PubMed: 18567616.
29. Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, et al. (2006) CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLOS ONE 1: e129. doi:10.1371/journal.pone.0000129. PubMed: 17205133.
30. Singh A, Dey AB, Mohan A, Sharma PK, Mitra DK, (2012) Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells. PLOS ONE 7: e44728. doi:10.1371/journal.pone.0044728. PubMed: 23028594.
31. Presicce P, Orsborn K, King E, Pratt J, Fichtenbaum CJ, et al. (2011) Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy. PLOS ONE 6: e28118. doi:10.1371/journal.pone.0028118. PubMed: 22162758.
32. Antunes I, Tolaini M, Kissenpfennig A, Iwashiro M, Kuribayashi K, et al. (2008) Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity 29: 782-794. doi:10.1016/j.immuni.2008.09.016. PubMed: 19006695.
33. Antunes I, Kassiotis G, (2010) Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice. J Virol 84: 12564-12575. doi:10.1128/JVI.01559-10. PubMed: 20943986.
34. Stoop JN, van der Molen RG, Baan CC, van der Laan LJW, Kuipers EJ, et al. (2005) Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-778. doi:10.1002/hep.20649. PubMed: 15791617.
35. Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, et al. (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103: 6659-6664. doi:10.1073/pnas.0509484103. PubMed: 16617117.
36. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354. doi:10.1093/intimm/dxm014. PubMed: 17329235.
37. Peng GP, Li SP, Wu W, Sun Z, Chen YQ, et al. (2008) Circulating CD4(+) CD25(+) regulatory T cells correlate with chronic hepatitis B infection. Immunology 123: 57-65. doi:10.1111/j.1365-2567.2007.02691.x. PubMed: 17764450.
38. McMahon BJ, (2009) The natural history of chronic hepatitis B virus infection. Hepatology 49: S45-S55. doi:10.1002/hep.22898. PubMed: 19399792.
39. Sun C, Fu B, Gao Y, Liao X, Sun R, et al. (2012) TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLOS Pathog 8: e1002594.
40. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. doi:10.1126/science.1079490. PubMed: 12522256.
41. Dejaco C, Duftner C, Schirmer M, (2006) Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol 36: 245-246; author reply: 10.1002/eji.200535651. PubMed: 1638096416380960.
42. Pillai V, Ortega SB, Wang CK, Karandikar NJ, (2007) Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 123: 18-29. doi:10.1016/j.clim.2007.03.219. PubMed: 17185041.
43. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37: 129-138. doi:10.1002/eji.200636435. PubMed: 17154262.
44. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, et al. (2005) Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66: 13-20. doi:10.1016/j.humimm.2004.05.016. PubMed: 15620457.
45. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, et al. (2007) Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19: 345-354. doi:10.1093/intimm/dxm014. PubMed: 17329235.
46. Floess S, Freyer J, Siewert C, Baron U, Olek S, et al. (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLOS Biol 5: 169-178. doi:10.1371/journal.pbio.0050169. PubMed: 17298177.
47. Janson PC, Winerdal ME, Marits P, Thörn M, Ohlsson R, et al. (2008) FOXP3 promoter demethylation reveals the committed Treg population in humans. PLOS ONE 3: e1612. doi:10.1371/journal.pone.0001612. PubMed: 18286169.
48. Liu J, Lluis A, Illi S, Layland L, Olek S, et al. (2010) T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker. PLOS ONE 5: e13267. doi:10.1371/journal.pone.0013267. PubMed: 20967272.
49. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A, (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. doi:10.1038/44385. PubMed: 10537110.
50. Sallusto F, Geginat J, Lanzavecchia A, (2004) Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 22: 745-763. doi:10.1146/annurev.immunol.22.012703.104702. PubMed: 15032595.
51. Stockinger B, Kassiotis G, Bourgeois C, (2004) CD4 T-cell memory. Semin Immunol 16: 295-303. doi:10.1016/j.smim.2004.08.010. PubMed: 15528074.
52. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3(+) T cells and, together with TGF-beta, generates IL-9(+) IL-10(+) Foxp3(-) effector T cells. Nat Immunol 9: 1347-1355. doi:10.1038/ni.1677. PubMed: 18997793.